The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | B | Blood and blood forming organs | |
| 2 | B02 | Antihemorrhagics | |
| 3 | B02B | Vitamin K and other hemostatics | |
| 4 | B02BX | Other systemic hemostatics | |
| 5 | B02BX01 | Etamsylate |
| Active Ingredient | Description | |
|---|---|---|
| Etamsylate |
Etamsylate is a synthetic antihaemorrhagic and angioprotective drug acting on the first step of haemostasis (endothelium-platelet interaction). By improving platelet adhesiveness and restoring capillary resistance, it is able to reduce bleeding time and blood losses. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| DICYNONE 250 Solution for injection | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| DICYNONE 500 Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
